USA: A new study published in the Journal of Diabetes and Its Complications suggests that tirzepatide, a novel dual ...

Some users of weight loss jabs have reported losing more than just the pounds-they've taken to online forums in their ...

ON THIS PAGEDigestive Problems'Ozempic Face'Oral Hygiene ChangesHair LossWomen's HealthSee more (11) Ozempic and other drugs in the GLP-1 receptor agonist family have rapidly become famous for ...

Data from a limited number of trials hint that GLP-1 use might improve erectile dysfunction and testosterone levels for men, but more research is needed to provide a clearer picture, researchers ...

A narrative review in The Journal of Nutrition suggests that whole-food plant diets may help prevent or improve erectile dysfunction (ED) by supporting vascular health and reducing risk factors ...

New research links semaglutide and tirzepatide, which are GLP-1 agonists used to treat type 2 diabetes and aid weight loss, to a rare eye disease that may cause vision loss.

Scholar Rock Reports Positive Phase 2 EMBRAZE Trial Results Demonstrating Statistically Significant Preservation of Lean Mass with Apitegromab During Tirzepatide-Induced Weight Loss ...

Provided by PR NewswireJun 16, 2025, 10:45:00 AM Lilly to offer all approved doses of Zepbound (tirzepatide) single-dose vials through LillyDirect Self Pay Pharmacy Solutions ...

Eli Lilly's dual GLP-1/GIP agonist tirzepatide has been shown to reduce the risk of worsening disease in people with heart failure and obesity in a phase 3 trial, the first to show a benefit on ...

Erectile dysfunction is the inability to achieve a penile erection sufficient for sexual intercourse. It can be physical or psychological in origin, and can have a profound effect on quality of life.